Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Thyroid hormones, including triiodothyronine (T3) and thyroxine (T4), regulate metabolism.
• Peripheral conversion of T4 to T3 is a key regulatory step.
• Beta-blockers like propranolol are used for hyperthyroid symptoms.

Purpose of the Study:

• To investigate the effect of propranolol on thyroid hormone levels (T3, reverse T3) in hyperthyroid and hypothyroid patients.
• To explore propranolol's potential role in the peripheral conversion of thyroxine.

Main Methods:

• Administered propranolol to 16 hyperthyroid patients and 10 hypothyroid patients (concomitantly with thyroxine).
• Measured serum T3, reverse T3 (rT3), and plasma propranolol concentrations.
• Observed changes in weight and thyroid-stimulating hormone (TSH) levels.

Main Results:

• Hyperthyroid patients showed decreased serum T3 and increased rT3 with propranolol, correlating with drug concentration.
• Weight loss ceased in hyperthyroid patients; weight gain occurred with T3 reduction.
• Hypothyroid patients on thyroxine and propranolol had lower mean serum T3.
• Propranolol withdrawal in hypothyroid patients led to increased T3, decreased rT3 and TSH, and weight loss.

Conclusions:

• Propranolol appears to directly inhibit peripheral conversion of T4 to T3 and rT3.
• The drug may have a clinically significant impact on thyroid hormone metabolism beyond symptom management.